Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant type 2 signaling in severe asthma.
Couillard, Simon Shrimanker, Rahul Chaudhuri, Rekha Mansur, Adel H McGarvey, Lorcan P Heaney, Liam G Fowler, Stephen J Bradding, Peter Pavord, Ian D Hinks, Timothy S C
Couillard, Simon
Shrimanker, Rahul
Chaudhuri, Rekha
Mansur, Adel H
McGarvey, Lorcan P
Heaney, Liam G
Fowler, Stephen J
Bradding, Peter
Pavord, Ian D
Hinks, Timothy S C
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2021-09-15
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, McGarvey LP, Heaney LG, Fowler SJ, Bradding P, Pavord ID, Hinks TSC. Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma. Am J Respir Crit Care Med. 2021 Sep 15;204(6):731-734. doi: 10.1164/rccm.202104-1040LEa
Type
Article